Product image of Ерибулин Адвц (Eribulin Mesylate) supplied by GNH India

Ерибулин Адвц

Active Ingredient:
Eribulin Mesylate
Origin:
EU

Ерибулин Адвц (Eribulin Mesylate)

Eribulin Mesylate is a chemotherapy medication used for cancer treatment. It belongs to the microtubule inhibitor class and is administered intravenously. This page provides neutral, factual information about its uses, effects, and handling.

Manufacturer / TM Owner

Advanz Pharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Eribulin Mesylate is primarily used to treat certain types of cancer, including metastatic breast cancer and liposarcoma. It works by stopping cancer cells from dividing and spreading. Patients often ask, 'what is Eribulin Mesylate used for' to understand its role in treatment plans. It is prescribed when other treatments have not been effective.

Side Effects

  • Eribulin Mesylate may cause side effects such as fatigue, nausea, or hair loss. Some patients experience changes in blood cell counts, which can increase infection risk. These effects vary by individual and should be monitored by a healthcare provider. Regular check-ups help manage any discomfort.

Precautions & Warnings

  • Eribulin Mesylate should only be handled and administered by healthcare professionals. Patients must inform their doctor about all medications and medical conditions before starting treatment. Avoid exposure to infections and stay hydrated. Follow all safety guidelines provided by your healthcare team.

Avoid Interactions

  • Eribulin Mesylate can interact with other drugs, including CYP3A4 inhibitors or inducers, which may affect its effectiveness. Alcohol and certain supplements may also interact. Always disclose all medications, including over-the-counter and herbal products, to your doctor. This helps prevent potential complications.

Frequently Asked Questions

Eribulin Mesylate is used to treat certain cancers, such as metastatic breast cancer and liposarcoma, when other treatments have not worked.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects include fatigue, nausea, and changes in blood cell counts. Always discuss side effects with your doctor.

Inform your doctor about all medications you are taking, as some may interact with Eribulin Mesylate.

Eribulin Mesylate may harm an unborn baby. Discuss pregnancy risks with your healthcare provider before starting treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eribulin Mesylate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT